IRadimed Corp
NASDAQ:IRMD
IRadimed Corp
Net Change in Cash
IRadimed Corp
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IRadimed Corp
NASDAQ:IRMD
|
Net Change in Cash
$2.3m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
6%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Change in Cash
$326m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Change in Cash
$1.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Net Change in Cash
$659m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Net Change in Cash
-$2.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-2%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Change in Cash
$701.3m
|
CAGR 3-Years
58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
See Also
What is IRadimed Corp's Net Change in Cash?
Net Change in Cash
2.3m
USD
Based on the financial report for Mar 31, 2024, IRadimed Corp's Net Change in Cash amounts to 2.3m USD.
What is IRadimed Corp's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
6%
The average annual Net Change in Cash growth rates for IRadimed Corp have been -28% over the past three years , -25% over the past five years , and 6% over the past ten years .